Abstract：Objective To explore clinical efficacy of Jinghua Weikang Capsules combined with quadruple therapy in the treatment of Helicobacter pylori (Hp) positive elderly chronic gastritis. Methods One hundred and twelve Hp positive elderly patients with chronic gastritis admitted to Dandong Central Hospital from March 2015 to September 2018 were selected and divided into control group and study group according to the random number table method, with 56 cases in each group. Control group was given quadruple therapy, and study group was treated with Jinghua Weikang Capsules on the basis of control group. Clinical efficacy, traditional Chinese medicine symptom score, inflammatory factors, Hp eradication rate and adverse reactions of two groups were compared. Results Total effective rate of study group was significantly higher than that of control group (P < 0.05). The eradication rate of Hp in study group was significantly higher than that in control group (P < 0.05). The scores of stomachache fullness, belching and acid regurgitation, stomachache, stomachache and xerostomia in two groups after 90 days of treatment were lower than those before treatment, and the scores in study group were lower than those in control group (P < 0.05). The levels of serum hs-CRP, IL-6 and TNF-α in two groups after 90 days treatment were lower than those before treatment, and the level in study group was lower than that in control group (P < 0.05). There was no significant difference in incidence of adverse reaction between two groups (P > 0.05). Conclusion Jinghua Weikang Capsules combined with quadruple therapy in the treatment of Hp positive elderly patients with chronic gastritis can rapidly improve clinical symptoms, reduce the level of inflammatory factors, and the medication is safe and effective, which has a certain clinical application value.
2020, Vol. 17 
京公网安备 11010502046598号